Updated:
Tongli Pharmaceuticals (USA), Inc.
Tongli Pharmaceuticals (USA), Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001052284, and its...
Overview
Tongli Pharmaceuticals (USA), Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001052284, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2013-06-28, it reported net income of USD 1,493,484; total assets of USD 22,060,023 for the fiscal period ended 2013-03-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Tongli Pharmaceuticals (USA), Inc.
- Former names in filing history
- American Tony Pharmaceuticals, Inc. (2008-09-24 to 2008-10-30); AIM SMART CORP (1999-06-14 to 2008-09-03)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- New York, NY, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001052284
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Operating cash flow |
|---|---|---|---|---|
| FY2012USD | $1.5M | $22.1M | $6.0M | |
| FY2011USD | $2.2M | $19.8M | -$285,025 |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 10-Q | FORM 10-Q | ||
| 10-Q | FORM 10-Q | ||
| 10-Q | FORM 10-Q | ||
| 10-K | FORM 10-K | ||
| 10-Q | FORM 10-Q | ||
| 10-Q | FORM 10-Q | ||
| 10-Q | FORM 10-Q | ||
| 10-K/A | AMENDMENT NO. 1 | ||
| 10-K | FORM 10-K | ||
| 8-K | CURRENT REPORT | ||
| 10-Q | 10-Q | ||
| 8-K | FORM 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Tongli Pharmaceuticals (USA), Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.